Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Diversified business group Barkby reported wider annual losses as performance was 'significantly' weighed down by pandemic impact.
For the period to 1 July 2021, pre-tax losses widened by £1.3 million to £4.4 million year-on-year, while revenue increased by £3.1 million to £15.1 million.
The wider loss was also driven by £1.0 million of start-up costs for Cambridge Sleep Sciences in 2021.
Looking ahead, the company said it was in a 'strong position to return to profitability, driven by its well-progressed and profitable commercial property development pipeline and we look forward to the next 12 months with confidence.'